“Affordability boards” to review expensive drugs

To rein in prescription drug prices, several states are considering new “affordability boards” to review expensive drugs and if it deems them too expensive, set a new, lower price that insurance plans would have to pay. Following a model by the National Academy for State Health Policy, several states, have introduced bills with Maryland’s bill having the most momentum so far. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.